Tildrakizumab in real‐life shows good efficacy in moderate‐to‐severe psoriasis regardless of previous use of biologic drugs and joint involvement
Luca Mastorino, Caterina Cariti, Sara Susca, Nadia Sciamarrelli, Silvia Borriello, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Paolo Dapavo, Pietro Quaglino, Simone Ribero
Topics & Concepts
DermatologyPsoriasisMedicineSection (typography)Computer scienceOperating systemPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAutoimmune Bullous Skin Diseases